Bartronics India Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "ASMS and Huwel to Launch Cubo, India s Revolutionary Point-of-Care Molecular Diagnostics Platform Built for the World.".
ASMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ASMS has announced a partnership with Huwel Lifesciences to launch Cubo, an ultra-compact and affordable RT-PCR diagnostics platform designed for decentralized healthcare settings. The platform can be deployed in rural clinics, district hospitals, mobile health units, and remote areas where access to centralized labs is limited. Cubo supports testing for tuberculosis, respiratory infections, influenza, viral panels, and other diagnostics. The companies claim a first-mover advantage in this fast-growing healthcare technology segment. Management highlighted that the product aims to bring advanced diagnostics to underserved markets, combining scientific precision with operational simplicity.
This announcement signals ASMS's strategic shift into health-tech through an innovative product launch, but provides no immediate financial impact. The success depends on adoption rates, regulatory clearings, and market acceptance post-launch. No revenue projections or order values were disclosed.